Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 145 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Axitinib for Patients at High Risk of Recurrence of Renal Cell Carcinoma – Adjuvant	Axitinib (Inlyta; AG-013736)	Renal cell carcinoma (RCC)	Renal Cancer	2018	View \| Download
Baloxavir marboxil for treatment of influenza A or B infection in otherwise healthy patients aged 12 years and older	Baloxavir marboxil (Xofluza; S-033188)	Influenza	Infectious Disease	2018	View \| Download
bb2121 for Relapsed and Refractory Multiple Myeloma	Idecabtagene vicleucel (Ide-cel; bb2121)	Multiple myeloma (MM)	Haematological Cancer and Lymphomas	2018	View \| Download
Bempedoic acid (monotherapy) and bempedoic acid/ezetimibe (fixed-dose combination) for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid (monotherapy) or bempedoic acid in combination with ezetimibe for primary hypercholesterolaemia or mixed dyslipidaemia	Bempedoic acid (ETC-1002; Nilemdo) , Ezetimibe (Ezetrol; MK-0653)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Bempedoic acid for primary hypercholesterolaemia or mixed dyslipidaemia in patients unable to reach cholesterol goals with the maximum tolerated dose of a statin	Bempedoic acid (ETC-1002; Nilemdo)	Mixed dyslipidaemia , Primary hypercholesterolaemia	Endocrine Nutritional and Metabolic Disorders	2018	View \| Download
Beraprost modified release in addition to treprostinil for pulmonary arterial hypertension	Esuberaprost (Beraprost-314d; BPS-314d-MR) , Treprostinil (Tyvaso; LIQ861; Orenitram; UT-15C; Remodulin; treprostinil sodium)	Pulmonary arterial hypertension (PAH)	Cardiovascular System , Respiratory System	2018	View \| Download
BPX‐501 to improve Immune Recovery and Graft versus Host Disease (GvHD) after Haploidentical Stem Cell Transplant	Rivogenlecleucel (BPX-501)	Graft versus host disease (GvHD) , Immunodeficiency	Immunology	2018	View \| Download
Brentuximab vedotin in addition to cyclophosphamide, doxorubicin, and prednisolone (CHP) for CD30+ mature T-cell lymphoma	Brentuximab vedotin (Adcetris; SGN-35) , CHP	Mature T-cell lymphoma	Haematological Cancer and Lymphomas	2018	View \| Download
Brigatinib for locally advanced or metastatic, ALK-positive, non-small cell lung cancer – first line	Brigatinib (Alunbrig; AP26113)	Non-small-cell lung cancer (NSCLC)	Lung and Respiratory Cancer	2018	View \| Download